Recurrence is established based on the Response Evaluation Criteria in Solid Tumours (RECIST) [9] CA125 levels, namely at least a twofold elevation of CA125 above the upper limit of normal (35 U/mL) on two occasions. This evidence concerns the gene MUC16 and neoplasm.